ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

In Their Own Words: A 64-page Internal Report with over 1,500 Faculty Comments on MD Anderson Morale

March 29, 2013

California Land Control Grant, Need Administrator

April 21, 1978

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991

NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy

June 24, 2011

Funding opportunities listed.

May 28, 2004

NCAB Committee To Propose Event Marking Cancer Act

August 2, 1991